Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-02-23+15,000→ 15,000 totalExercise: $2.50Exp: 2033-02-22→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date.